Healing of intrabony defects and its relationship to root canal therapy. A histologic and histometric study in dogs.
The purpose of this study was to evaluate the importance of root canal therapy in the healing process of severe intrabony defects. Four beagle dogs were used and 32 interproximal intrabony defects, up to the apical third, were created. Wire ligatures were placed into these defects for plaque accumulation. Three weeks later, the ligatures were removed and 4 different treatment modalities were employed: group 1) scaling and root planing (SRP); group 2) modified Widman flap (MWF); group 3) modified Widman flap and root canal therapy performed at the same time (RCT/MWF); and group 4) modified Widman flap and root canal therapy performed 3 weeks after the surgical procedure (MWF + RCT). Postoperative oral hygiene was obtained by spraying a 0.12% chlorhexidine solution 3 times a week. The animals were sacrificed 7 weeks after treatment. Blocks were obtained and processed for routine histology. Results were expressed as a percentage of the total defect length (TDL). No differences were observed when SRP was compared to MWF. New bone formation (BF) presented better results for SRP (43.4%) and MWF (53.4%) when compared to RCT/MWF (15.5%). New cementum formation (CF) presented better results for SRP (59.8%) and MWF (64.6%) when compared to RCT/MWF (19.3%) and MWF + RCT (31.5%). Connective tissue repair (CTR) presented better results for SRP (72.4%) and MWF (74.2%) when compared to RCT/MWF (47.5%) and MWF + RCT (44.4%). Results were statistically significant at the level of 0.05. Within the limits of this study, it was concluded that root canal therapy performed simultaneously or 3 weeks after surgery modified the healing of intrabony defects, impairing new bone formation, new cementum formation and new attachment.
Lima
L A
LA
Division of Periodontics, University of Texas, Health Science Center, Houston, USA.
Anderson
G B
GB
Wang
M M
MM
Nasjleti
C E
CE
Morrison
E C
EC
Kon
S
S
Caffesse
R G
RG
D016301:Alveolar Bone Loss / Q000473:pathology* / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D000539:Alveolar Process / Q000473:pathology / Q000503:physiopathology; D000704:Analysis of Variance; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002710:Chlorhexidine / Q000627:therapeutic use; D003094:Collagen; D003238:Connective Tissue / Q000473:pathology / Q000503:physiopathology; D003739:Dental Cementum / Q000473:pathology / Q000503:physiopathology; D003773:Dental Plaque / Q000503:physiopathology / Q000628:therapy; D012534:Dental Scaling; D003804:Dentin / Q000473:pathology; D004285:Dogs; D004846:Epithelial Attachment / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D009067:Mouthwashes; D010012:Osteogenesis; D011897:Random Allocation; D012390:Root Canal Therapy; D016745:Root Planing; D013524:Surgical Flaps / Q000379:methods; D014945:Wound Healing
D000891:Anti-Infective Agents, Local; D009067:Mouthwashes; D003094:Collagen; D002710:Chlorhexidine